Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Notification of Results

20 Aug 2009 07:00

RNS Number : 7202X
ABCAM Plc
20 August 2009
 



For Immediate Release

20 August 2009

ABCAM PLC

("Abcam" or "the Company")

Notification of Preliminary Results

Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue, will announce its preliminary results for the twelve months ended 30 June 2009 on Tuesday 8 September 2009.

An analyst meeting will be held at 10:30am on Tuesday 8 September at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.

For further information please contact

Abcam + 44 (0) 1223 696000 

Jonathan Milner, Chief Executive Officer 

Jeff Iliffe, Chief Financial Officer 

www.abcam.com 

 

Numis Securities + 44 (0) 20 7260 1000 

Michael Meade / Nick Westlake - Nominated Adviser

James Black - Corporate Broking

Buchanan Communications + 44 (0) 20 7466 5000 

Mark Court / Mary-Jane Johnson / Stasa Filiplic

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORCKCKNPBKDDFD
Date   Source Headline
29th Oct 20212:42 pmRNSTotal Voting Rights
27th Oct 20217:00 amRNSCompletion of BioVision Acquisition
12th Oct 20214:46 pmRNSHolding(s) in Company
11th Oct 20214:21 pmRNSBlock listing Interim Review
6th Oct 202110:35 amRNSHolding(s) in Company
24th Sep 20214:03 pmRNSDirector/PDMR Shareholding
13th Sep 202112:00 pmRNSInterim results for the 6 and 12 month periods
1st Sep 20214:02 pmRNSTotal Voting Rights
1st Sep 202112:00 pmRNSTransition Report on 20-F and Notice of Results
17th Aug 20217:52 pmEQSThis is a test - Please ignore
13th Aug 20217:00 amRNSDirectorate Change
2nd Aug 202112:57 pmRNSTotal Voting Rights
2nd Aug 20217:00 amRNSAbcam to Acquire BioVision for $340 million
9th Jul 20212:34 pmRNSBlock listing Interim Review
1st Jul 20214:22 pmRNSTotal Voting Rights
1st Jul 20214:03 pmRNSResult of General Meeting
1st Jul 202112:00 pmRNSPre-Close Trading Update
2nd Jun 20219:54 amRNSTotal Voting Rights
2nd Jun 20218:30 amRNSNotice of Year End Change and General Meeting
19th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTotal Voting Rights
1st Apr 20213:11 pmRNSTotal Voting Rights
12th Mar 20212:55 pmRNSDirector/PDMR Shareholding
11th Mar 202111:46 amRNSDirector/PDMR Shareholding - Replacement
10th Mar 20214:50 pmRNSDirector/PDMR Shareholding
8th Mar 202112:02 pmRNSInterim Results for 6 months ended 31 Dec 2020
1st Mar 20215:08 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSNotice of Results
17th Feb 202112:00 pmRNSAbcam presenting at the SVB Leerink Conference
4th Feb 20213:24 pmRNSDirector/PDMR Shareholding
1st Feb 20219:27 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSDirectorate Change
14th Jan 20213:26 pmRNSHolding(s) in Company
11th Jan 202112:00 pmRNSHalf year trading update
4th Jan 202111:03 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSAbcam plc presenting at JPM Healthcare Conference
21st Dec 20207:00 amRNSNotification of Trading Update
17th Dec 20209:35 amRNSHolding(s) in Company
4th Dec 20202:32 pmRNSResult of AGM
1st Dec 20204:46 pmRNSTotal Voting Rights
4th Nov 202010:33 amRNSDirector/PDMR Shareholding
3rd Nov 20201:30 pmRNSConsultation on 2020 LTIP Awards
3rd Nov 20201:30 pmRNSAnnual Report, Impact Report and Notice of AGM
2nd Nov 202010:49 amRNSTotal Voting Rights
26th Oct 20203:45 pmRNSAbcam Announces Closing of Offering
23rd Oct 20207:00 amRNSExercise of Over-allotment Option
22nd Oct 20207:00 amRNSPricing of Offering on NASDAQ
19th Oct 202012:15 pmRNSOffering and Application to List on Nasdaq
5th Oct 20207:01 amRNSRegistration Statement for Proposed Offering Filed
5th Oct 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.